Description:
A drug used alone or with other drugs to treat adults and children aged 1 year and older with certain types of chronic myeloid leukemia or acute lymphoblastic leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. Dasatinib blocks BCR::ABL and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called BMS-354825 and Sprycel.
